CODX - Utang jangka dawa perusahaan Co-Diagnostics Corp

Co-Diagnostics, Inc. (CODX) develops automated PCR testing systems that eliminate manual labor and enhance diagnostic accuracy. The business relies on stable demand for infection detection, providing resilience against economic downturns. The long-term liability ratio is 0.00. The asset's market dynamics reflect the growth of a company that has nearly reached the automation ceiling in DNA sequencing and biodata processing.

This indicator captures the total volume of liabilities with a maturity of more than one year, allowing for an assessment of the issuer's financial stability and the risk of frozen cash flows during downturns. By analyzing the company's long-term debt, an investor determines the balance between leverage and solvency. For Co-Diagnostics, Inc. (CODX), this metric reflects the cost of transforming the business toward the creation of a diagnostic IT platform amid falling demand for PCR tests.